Skip to content
← Full study record

NCT03172624 · MORE INFO

Limitations, agreements, and source contact

Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer · Source last updated 2025-12-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
hoa@mskcc.org
organization
Memorial Sloan Kettering Cancer Center
phone
646-888-4235
title
Dr. Alan Ho, MD, PhD
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
hoa@mskcc.org
organization
Memorial Sloan Kettering Cancer Center
phone
646-888-4235
title
Dr. Alan Ho, MD, PhD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice